Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133(+) Cell Populations and Suppressing ERK/P70S6K Signaling

por Chai, Xinqun, Chu, Hongpeng, Yang, Xuan, Meng, Yuanpu, Shi, Pengfei, Gou, Shanmiao
Publicado 2015